| Ident. | Authors (with country if any) | Title |
|---|
| 004892 (2013) |
Frank G. Holz [Allemagne] ; Francesco Bandello [Italie] ; Mark Gillies [Australie] ; Paul Mitchell [Australie] ; Aaron Osborne [Suisse] ; Tom Sheidow [Canada] ; Eric Souied [France] ; Marta S. Figueroa [Espagne] ; Francesco Bandello ; Christopher Brand ; Mark Gillies ; Frank G. Holz ; Adrian Koh ; Paul Mitchell ; Aaron Osborne ; Ursula Schmidt-Erfurth ; N. Sharma ; Tom Sheidow ; Eric Souied ; Marta S. Figueroa ; Steve Winyard | Safety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programme |
| 005546 (2012) |
Matthieu Sailly [France] ; Rod Whiteley [Qatar, Australie] ; Amanda Johnson [Qatar, Royaume-Uni] | Doppler ultrasound and tibial tuberosity maturation status predicts pain in adolescent male athletes with Osgood-Schlatter's disease: a case series with comparison group and clinical interpretation |
| 006497 (2011) |
Charmaine S. Tam [Australie, France, États-Unis] ; Leonie K. Heilbronn [Australie] ; Corneliu Henegar [France] ; Melanie Wong [Australie] ; Christopher T. Cowell [Australie] ; Mark J. Cowley [Australie] ; Warren Kaplan [Australie] ; Karine Clément [France] ; Louise A. Baur [Australie] | An early inflammatory gene profile in visceral adipose tissue in children |
| 007064 (2010) |
Christophe Le Tourneau [France, Niger] ; Albiruni R A. Razak [Canada] ; Christine Levy [France] ; Valentin Calugaru [France] ; Olivier Galatoire [France] ; Rémi Dendale [France] ; Laurence Desjardins [France] ; Hui K. Gan [Australie] | Role of chemotherapy and molecularly targeted agents in the treatment of adenoid cystic carcinoma of the lacrimal gland |
| 007092 (2010) |
Lars Engebretsen [Suisse, Norvège] ; Kathrin Steffen [Suisse, Norvège] ; Joseph Alsousou [Royaume-Uni] ; Eduardo Anitua [Espagne] ; Norbert Bachl [Autriche] ; Roger Devilee [Pays-Bas] ; Peter Everts [Pays-Bas] ; Bruce Hamilton [Qatar] ; Johnny Huard [États-Unis] ; Peter Jenoure [Suisse] ; Francois Kelberine [France] ; Elizaveta Kon [Italie] ; Nicola Maffulli [Royaume-Uni] ; Gordon Matheson [États-Unis] ; Omer Mei-Dan [Israël] ; Jacques Menetrey [Suisse] ; Marc Philippon [États-Unis] ; Pietro Randelli [Italie] ; Patrick Schamasch [Suisse] ; Martin Schwellnus [Afrique du Sud] ; Alan Vernec [Canada] ; Geoffrey Verrall [Australie] | IOC consensus paper on the use of platelet-rich plasma in sports medicine |
| 009A25 (2006) |
Philippe Roche [Royaume-Uni, France] ; James Brown [Royaume-Uni] ; Adam Denley [Australie, États-Unis] ; Briony E. Forbes [Australie] ; John C. Wallace [Australie] ; E. Yvonne Jones [Royaume-Uni] ; Robert M. Esnouf [Royaume-Uni] | Computational model for the IGF‐II/IGF2r complex that is predictive of mutational and surface plasmon resonance data |
| 00A933 (2004) |
C. Gicquel [France] ; J. Weiss [Australie] ; J. Amiel [France] ; V. Gaston [France] ; Y. Le Bouc [France] ; C D Scott [Australie] | Epigenetic abnormalities of the mannose-6-phosphate/IGF2 receptor gene are uncommon in human overgrowth syndromes |
| 00AE64 (2003) |
Gregory S. Schultz ; R. Gary Sibbald [Canada] ; Vincent Falanga ; Elizabeth A. Ayello ; Caroline Dowsett ; Keith Harding ; Marco Romanelli [Italie] ; Michael C. Stacey [Australie] ; Luc Teot [France] ; Wolfgang Vanscheidt [Allemagne] | Wound bed preparation: a systematic approach to wound management |
| 00AE93 (2003) |
N. Diaz-Meyer [États-Unis] ; C D Day [États-Unis] ; K. Khatod [États-Unis] ; E R Maher [Royaume-Uni] ; W. Cooper [Royaume-Uni] ; W. Reik [Royaume-Uni] ; C. Junien [France] ; G. Graham [Canada] ; E. Algar [Australie] ; V M Der Kaloustian [Canada] ; M J Higgins [États-Unis] | Silencing of CDKN1C (p57KIP2) is associated with hypomethylation at KvDMR1 in Beckwith–Wiedemann syndrome |
| 00AF83 (2003) |
Jason S. Carroll [Australie] ; Danielle K. Lynch [Australie] ; Alexander Swarbrick [Australie] ; Jack-Michel Renoir [France] ; Boris Sarcevic [Australie] ; Roger J. Daly [Australie] ; Elizabeth A. Musgrove [Australie] ; Robert L. Sutherland [Australie] | p27Kip1 induces quiescence and growth factor insensitivity in tamoxifen-treated breast cancer cells |
| 00B382 (2002) |
Ian A. Darby [Australie] ; Teresa Bisucci [Australie] ; Brigitte Pittet [Suisse] ; Stefania Garbin [Italie] ; Giulio Gabbiani [Suisse] ; Alexis Desmoulière [France] | Skin flap‐induced regression of granulation tissue correlates with reduced growth factor and increased metalloproteinase expression |
| 00B424 (2002) |
Jerome Rossert ; William M. Mcclellan ; Simon D. Roger [Australie] ; Dierik L. Verbeelen [Belgique] | Epoetin treatment: what are the arguments to expect a beneficial effect on renal disease progression? |
| 00B482 (2002) |
Frédéric Bernard [France, Australie] ; Caroline Thomas ; Jean Francois Emile ; Timothy Hercus ; Bruno Cassinat ; Christine Chomienne ; Jean Donadieu | Transient hematologic and clinical effect of E21R in a child with end-stage juvenile myelomonocytic leukemia |
| 00B945 (2001) |
Victor J. Dzau ; Kenneth Bernstein ; David Celermajer [États-Unis] ; Jerome Cohen ; Björn Dahlöf ; John Deanfield ; Javier Diez ; Helmut Drexler ; Roberto Ferrari ; Wiek Van Gilst ; Lennart Hansson ; Burkhard Hornig ; Ahsan Husain ; Colin Johnston ; Harold Lazar ; Eva Lonn [Canada] ; Thomas Lüscher ; John Mancini [Canada] ; Albert Mimran ; Carl Pepine ; Ton Rabelink ; Willem Remme ; Luis Ruilope ; Marcel Ruzicka [Canada] ; Heribert Schunkert ; Karl Swedberg [États-Unis] ; Thomas Unger ; Douglas Vaughan ; Michael Weber | The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data |
| 00B976 (2001) |
Hubert Hondermarck [France] ; Anne-Sophie Vercoutter-Edouart [France] ; Françoise Révillion [France] ; Jérôme Lemoine [France] ; Ikram El-Yazidi-Belkoura [France] ; Victor Nurcombe [Australie] ; Jean-Philippe Peyrat [France] | Proteomics of breast cancer for marker discovery and signal pathway profiling |
| 00BE62 (2000) |
Anne-Sophie Vercoutter-Edouart [France] ; Jérôme Lemoine [France] ; Chanel E. Smart [Australie] ; Victor Nurcombe [Australie] ; Bénoni Boilly [France] ; Jean-Philippe Peyrat [France] ; Hubert Hondermarck [France] | The mitogenic signaling pathway for fibroblast growth factor-2 involves the tyrosine phosphorylation of cyclin D2 in MCF-7 human breast cancer cells |
| 00BF65 (2000) |
G. Vajta [Danemark, Australie] ; T. T. Peura [Australie] ; P. Holm [Danemark] ; A. Páldi [France] ; T. Greve [Danemark] ; A. O. Trounson [Australie] ; H. Callesen [Danemark] | New method for culture of zona‐included or zona‐free embryos: The Well of the Well (WOW) system |
| 00BF69 (2000) |
M. A Cake [Australie] ; R. A Read [Australie] ; B. Guillou [France] ; P. Ghosh [Australie] | Modification of articular cartilage and subchondral bone pathology in an ovine meniscectomy model of osteoarthritis by avocado and soya unsaponifiables (ASU) |
| 00BF98 (2000) |
B. Boilly [France] ; A. S. Vercoutter-Edouart [France] ; H. Hondermarck [France] ; V. Nurcombe [Australie] ; X. Le Bourhis [France] | FGF signals for cell proliferation and migration through different pathways |
| 00C131 (2000) |
Richard C. Bates [Australie] ; Nathaniel S. Edwards [États-Unis] ; Jonathon D. Yates [Australie] | Spheroids and cell survival |
| 00C272 (2000) |
N. Favre-Felix [France] ; M. Martin [France] ; E. Maraskovsky [Australie] ; A. Fromentin [France] ; M. Moutet [France] ; E. Solary [France] ; F. Martin [France] ; B. Bonnotte [France] | Flt3 ligand lessens the growth of tumors obtained after colon cancer cell injection in rats but does not restore tumor-suppressed dendritic cell function |
